Cargando…
A Double‐Blind, Double‐Dummy, Flexible‐Design Randomized Multicenter Trial: Early Safety of Single‐ Versus Divided‐Dose Rabbit Anti‐Thymocyte Globulin Induction in Renal Transplantation
A previous nonblinded, randomized, single‐center renal transplantation trial of single‐dose rabbit anti‐thymocyte globulin induction (SD‐rATG) showed improved efficacy compared with conventional divided‐dose (DD‐rATG) administration. The present multicenter, double‐blind/double‐dummy STAT trial (Sin...
Autores principales: | Stevens, R. B., Wrenshall, L. E., Miles, C. D., Farney, A. C., Jie, T., Sandoz, J. P., Rigley, T. H., Osama Gaber, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069643/ https://www.ncbi.nlm.nih.gov/pubmed/26696251 http://dx.doi.org/10.1111/ajt.13659 |
Ejemplares similares
-
A Randomized 2×2 Factorial Trial, Part 1: Single-Dose Rabbit Antithymocyte Globulin Induction May Improve Renal Transplantation Outcomes
por: Stevens, R. Brian, et al.
Publicado: (2015) -
Complications of rabbit anti-thymocyte globulin induction immunosuppression in HIV-infected kidney transplant recipients
por: Al Jurdi, Ayman, et al.
Publicado: (2022) -
Rabbit anti‐thymocyte globulin for the prevention of acute rejection in kidney transplantation
por: Alloway, Rita R., et al.
Publicado: (2019) -
Induction of procalcitonin in liver transplant patients treated with anti-thymocyte globulin
por: Zazula, Roman, et al.
Publicado: (2007) -
A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology
por: Stevens, R. Brian, et al.
Publicado: (2015)